Upcoming updates
for 2026-2027

May 2026

Side Effects of Antidepressants Part 5 (Hyperprolactinemia)

Sebastián Malleza, M.D., Psychopharmacology Institute
Included in Silver, Gold, Silver extended, Gold extended, Gold – fr, Gold extended – fr, Silver – fr or Silver extended – fr Memberships.
June 2026

Quick Take Vol. 87

Scott R. Beach, M.D., Harvard Medical School – Massachusetts General Hospital
Included in Silver, Gold, Silver extended, Gold extended, Silver – fr, Silver extended – fr, Gold – fr or Gold extended – fr Memberships.

Prescribing Psychotropics in Medically Complex Patients: What Clinicians Need to Know

Siobhan Gee, Ph.D.
Included in Bronze, Silver, Gold, Bronze extended, Silver extended, Gold extended, Bronze – fr, Bronze extended – fr, Silver – fr, Silver extended – fr, Gold – fr or Gold extended – fr Memberships.

Bipolar Disorder Pharmacotherapy – Interview

To Be Announced
Included in Silver, Gold, Silver extended, Gold extended, Gold – fr, Gold extended – fr, Silver – fr or Silver extended – fr Memberships.

Cardiac Effects of Antidepressants: A Clinical Guide

Sebastián Malleza, M.D., Psychopharmacology Institute
Included in Silver, Gold, Silver extended, Gold extended, Gold – fr, Gold extended – fr, Silver – fr or Silver extended – fr Memberships.
July 2026

Quick Take Vol. 88

Scott R. Beach, M.D., Harvard Medical School – Massachusetts General Hospital
Included in Silver, Gold, Silver extended, Gold extended, Silver – fr, Silver extended – fr, Gold – fr or Gold extended – fr Memberships.

Ophthalmologic Effects of Antidepressants: A Clinical Guide

Sebastián Malleza, M.D., Psychopharmacology Institute
Included in Silver, Gold, Silver extended, Gold extended, Gold – fr, Gold extended – fr, Silver – fr or Silver extended – fr Memberships.

Nutraceuticals and Phytoceuticals for Mood and Anxiety Disorders

Noshene E. Ranjbar, M.D., University of Arizona College of Medicine
Included in Bronze, Silver, Gold, Bronze extended, Silver extended, Gold extended, Bronze – fr, Bronze extended – fr, Silver – fr, Silver extended – fr, Gold – fr or Gold extended – fr Memberships.

Metabolic Psychiatry

Shebani Sethi M.D., M.D., Stanford University
Included in Silver, Gold, Silver extended, Gold extended, Gold – fr, Gold extended – fr, Silver – fr or Silver extended – fr Memberships.

Lamotrigine Guide: Pharmacology, Indications, Dosing Guidelines and Adverse Effects

Sebastián Malleza, M.D., Psychopharmacology Institute
Included in Silver, Gold, Silver extended, Gold extended, Gold – fr, Gold extended – fr, Silver – fr or Silver extended – fr Memberships.
August 2026

Quick Take Vol. 89

Scott R. Beach, M.D., Harvard Medical School – Massachusetts General Hospital
Included in Silver, Gold, Silver extended, Gold extended, Silver – fr, Silver extended – fr, Gold – fr or Gold extended – fr Memberships.

Pharmacotherapy for Cannabis Use Disorder

Joao P. De Aquino, M.D., Yale University School of Medicine
Included in Bronze, Silver, Gold, Bronze extended, Silver extended, Gold extended, Bronze – fr, Bronze extended – fr, Silver – fr, Silver extended – fr, Gold – fr or Gold extended – fr Memberships.

Antipsychotic Blood Levels in Practice – Interview

To Be Announced
Included in Silver, Gold, Silver extended, Gold extended, Gold – fr, Gold extended – fr, Silver – fr or Silver extended – fr Memberships.

Valproate Guide: Pharmacology, Indications, Dosing Guidelines and Adverse Effects

Sebastián Malleza, M.D., Psychopharmacology Institute
Included in Silver, Gold, Silver extended, Gold extended, Gold – fr, Gold extended – fr, Silver – fr or Silver extended – fr Memberships.
September 2026

Quick Take Vol. 90

Scott R. Beach, M.D., Harvard Medical School – Massachusetts General Hospital
Included in Silver, Gold, Silver extended, Gold extended, Silver – fr, Silver extended – fr, Gold – fr or Gold extended – fr Memberships.

Pharmacological Management of Primary Insomnia

To Be Announced
Included in Bronze, Silver, Gold, Bronze extended, Silver extended, Gold extended, Bronze – fr, Bronze extended – fr, Silver – fr, Silver extended – fr, Gold – fr or Gold extended – fr Memberships.

Lithium Guide: Pharmacology, Indications, Dosing Guidelines and Adverse Effects

Sebastián Malleza, M.D., Psychopharmacology Institute
Included in Silver, Gold, Silver extended, Gold extended, Gold – fr, Gold extended – fr, Silver – fr or Silver extended – fr Memberships.
October 2026

Quick Take Vol. 91

Scott R. Beach, M.D., Harvard Medical School – Massachusetts General Hospital
Included in Silver, Gold, Silver extended, Gold extended, Silver – fr, Silver extended – fr, Gold – fr or Gold extended – fr Memberships.

Buspirone Guide: Pharmacology, Indications, Dosing Guidelines and Adverse Effects

Sebastián Malleza, M.D., Psychopharmacology Institute
Included in Silver, Gold, Silver extended, Gold extended, Gold – fr, Gold extended – fr, Silver – fr or Silver extended – fr Memberships.

Pharmacotherapy of Alcohol Use Disorder – Interview

Kevin A. Sevarino, M.D.C.M., Ph.D., Yale School of Medicine
Included in Silver, Gold, Silver extended, Gold extended, Gold – fr, Gold extended – fr, Silver – fr or Silver extended – fr Memberships.

Switching Antipsychotics in Clinical Practice 2026 update

Brian Miller, M.D., Ph.D., M.P.H., Augusta University
Included in Bronze, Silver, Gold, Bronze extended, Silver extended, Gold extended, Bronze – fr, Bronze extended – fr, Silver – fr, Silver extended – fr, Gold – fr or Gold extended – fr Memberships.
November 2026

Quick Take Vol. 92

Scott R. Beach, M.D., Harvard Medical School – Massachusetts General Hospital
Included in Silver, Gold, Silver extended, Gold extended, Silver – fr, Silver extended – fr, Gold – fr or Gold extended – fr Memberships.

Atomoxetine Guide: Pharmacology, Indications, Dosing Guidelines and Adverse Effects

Sebastián Malleza, M.D., Psychopharmacology Institute
Included in Silver, Gold, Silver extended, Gold extended, Gold – fr, Gold extended – fr, Silver – fr or Silver extended – fr Memberships.

Antidepressant Withdrawal Effects and Safe Deprescribing – Interview

Mark Horowitz, M.D., National Health Service (NHS)
Included in Silver, Gold, Silver extended, Gold extended, Gold – fr, Gold extended – fr, Silver – fr or Silver extended – fr Memberships.

Pharmacotherapies for Stimulant Use Disorder (Update)

Andrew Saxon, M.D., University of Washington School of Medicine
Included in Bronze, Silver, Gold, Bronze extended, Silver extended, Gold extended, Bronze – fr, Bronze extended – fr, Silver – fr, Silver extended – fr, Gold – fr or Gold extended – fr Memberships.

Methylphenidate Guide: Pharmacology, Indications, Dosing Guidelines and Adverse Effects

Sebastián Malleza, M.D., Psychopharmacology Institute
Included in Silver, Gold, Silver extended, Gold extended, Gold – fr, Gold extended – fr, Silver – fr or Silver extended – fr Memberships.
December 2026

Diagnosis and Management of Generalized Anxiety Disorder: Focus on Treatment-Resistant Cases

David Osser, M.D., Harvard Medical School
Included in Bronze, Silver, Gold, Bronze extended, Silver extended, Gold extended, Bronze – fr, Bronze extended – fr, Silver – fr, Silver extended – fr, Gold – fr or Gold extended – fr Memberships.

Quick Take Vol. 93

Scott R. Beach, M.D., Harvard Medical School – Massachusetts General Hospital
Included in Silver, Gold, Silver extended, Gold extended, Silver – fr, Silver extended – fr, Gold – fr or Gold extended – fr Memberships.

Mood and Anxiety Disorders During Perimenopause – Interview

Katie Unverferth, M.D., U.C.L.A.
Included in Silver, Gold, Silver extended, Gold extended, Gold – fr, Gold extended – fr, Silver – fr or Silver extended – fr Memberships.

Amphetamines Guide: Pharmacology, Indications, Dosing Guidelines and Adverse Effects

Sebastián Malleza, M.D., Psychopharmacology Institute
Included in Silver, Gold, Silver extended, Gold extended, Gold – fr, Gold extended – fr, Silver – fr or Silver extended – fr Memberships.
January 2027

Quick Take Vol. 94

Scott R. Beach, M.D., Harvard Medical School – Massachusetts General Hospital
Included in Silver, Gold, Silver extended, Gold extended, Silver – fr, Silver extended – fr, Gold – fr or Gold extended – fr Memberships.

Updates on Geriatric Psychopharmacology – Interview

Lauren B. Gerlach, D.O., M.S., University of Michigan Department of Psychiatry
Included in Silver, Gold, Silver extended, Gold extended, Gold – fr, Gold extended – fr, Silver – fr or Silver extended – fr Memberships.

Drug-Drug Interactions in Psychopharmacology.

To Be Announced
Included in Bronze, Silver, Gold, Bronze extended, Silver extended, Gold extended, Bronze – fr, Bronze extended – fr, Silver – fr, Silver extended – fr, Gold – fr or Gold extended – fr Memberships.

ADHD Medications: A Comprehensive Formulations Guide

Sebastián Malleza, M.D., Psychopharmacology Institute
Included in Silver, Gold, Silver extended, Gold extended, Gold – fr, Gold extended – fr, Silver – fr or Silver extended – fr Memberships.
February 2027

Quick Take Vol. 95

Scott R. Beach, M.D., Harvard Medical School – Massachusetts General Hospital
Included in Silver, Gold, Silver extended, Gold extended, Silver – fr, Silver extended – fr, Gold – fr or Gold extended – fr Memberships.

Brexpiprazole Guide: Pharmacology, Indications, Dosing Guidelines and Adverse Effects

Sebastián Malleza, M.D., Psychopharmacology Institute
Included in Silver, Gold, Silver extended, Gold extended, Gold – fr, Gold extended – fr, Silver – fr or Silver extended – fr Memberships.

Psychotropic-Induced Movement Disorders and Cognitive Side Effects (Update) – Interview

Gregory Pontone, M.D., M.H.S., University of Florida College of Medicine
Included in Silver, Gold, Silver extended, Gold extended, Gold – fr, Gold extended – fr, Silver – fr or Silver extended – fr Memberships.
March 2027

Quick Take Vol. 96

Scott R. Beach, M.D., Harvard Medical School – Massachusetts General Hospital
Included in Silver, Gold, Silver extended, Gold extended, Silver – fr, Silver extended – fr, Gold – fr or Gold extended – fr Memberships.

Cariprazine Guide: Pharmacology, Indications, Dosing Guidelines and Adverse Effects

Sebastián Malleza, M.D., Psychopharmacology Institute
Included in Silver, Gold, Silver extended, Gold extended, Gold – fr, Gold extended – fr, Silver – fr or Silver extended – fr Memberships.

Pharmacotherapy Bipolar Depression: Strategies for Everyday Management – Interview

Chris Aiken, M.D., NYU and WFU Medical Schools
Included in Silver, Gold, Silver extended, Gold extended, Gold – fr, Gold extended – fr, Silver – fr or Silver extended – fr Memberships.

Lumateperone Guide: Pharmacology, Indications, Dosing Guidelines and Adverse Effects

Sebastián Malleza, M.D., Psychopharmacology Institute
Included in Silver, Gold, Silver extended, Gold extended, Gold – fr, Gold extended – fr, Silver – fr or Silver extended – fr Memberships.
April 2027

Quick Take Vol. 97

Scott R. Beach, M.D., Harvard Medical School – Massachusetts General Hospital
Included in Silver, Gold, Silver extended, Gold extended, Silver – fr, Silver extended – fr, Gold – fr or Gold extended – fr Memberships.

Treatment-Resistant Obsessive-Compulsive Disorder (Update) – Interview

Robert Hudak, M.D., University of Pittsburgh
Included in Silver, Gold, Silver extended, Gold extended, Gold – fr, Gold extended – fr, Silver – fr or Silver extended – fr Memberships.
May 2027

Addiction Psychopharmacology in Patients with Medical Comorbidities – Interview

Kevin A. Sevarino, M.D.C.M., Ph.D., Yale School of Medicine
Included in Silver, Gold, Silver extended, Gold extended, Gold – fr, Gold extended – fr, Silver – fr or Silver extended – fr Memberships.
Get Instant Access Now

Información sobre la acreditación CME

Médicos – Declaración de acreditación CME

The activities below have been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Medical Academy LLC and the Psychopharmacology Institute. Medical Academy LLC is accredited by the ACCME to provide AMA PRA Category 1 Credits™ for physicians.

This CME program issues AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Download Accreditation Information (PDF)

Profesionales de enfermería – Declaración de acreditación CME

The activities below have been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Medical Academy LLC and the Psychopharmacology Institute. Medical Academy LLC is accredited by the ACCME to provide AMA PRA Category 1 Credits™ for physicians.

This CME program issues AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

El ANCC acepta los créditos AMA PRA Category 1 Credit(s)™ como horas de contacto, según el siguiente cálculo: 1 CME = 1 hora de contacto.. 

Download Accreditation Information (PDF)

Asistentes médicos – Declaración de acreditación CME

The activities below have been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Medical Academy LLC and the Psychopharmacology Institute. Medical Academy LLC is accredited by the ACCME to provide AMA PRA Category 1 Credits™ for physicians.

This CME program issues AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Download Accreditation Information (PDF)

Autoevaluación para el mantenimiento de la certificación (SA) – Declaración de acreditación
  • Psychopharmacology Institute Self-Assessment Program 2026

Dates: April 1, 2026 – April 1, 2029

The American Board of Psychiatry and Neurology has reviewed the Psychopharmacology Institute Self-Assessment Program 2026 and has approved this activity as part of a comprehensive Self-Assessment activity, which is mandated by the ABMS as a necessary component of Continuing Certification.

  • Psychopharmacology Institute Self-Assessment Program 2025

Dates: April 1, 2025 – April 1, 2028

The American Board of Psychiatry and Neurology has reviewed the Psychopharmacology Institute Self-Assessment Program 2025 and has approved this activity as part of a comprehensive Self-Assessment activity, which is mandated by the ABMS as a necessary component of Continuing Certification.

  • Psychopharmacology Institute Self-Assessment Program 2024

Dates: April 1, 2024 – April 1, 2027

The American Board of Psychiatry and Neurology has reviewed the Psychopharmacology Institute Self-Assessment Program 2024 and has approved this activity as part of a comprehensive Self-Assessment activity, which is mandated by the ABMS as a necessary component of Continuing Certification.